Table 3.

Mean improvement at 8 weeks

	AE BCVA, logMARa	RDS, log arcseca	Extent of suppression scotoma, log degreesa	Depth of suppression, CBIa
Total (N = 63)	0.14 ± 0.08b	0.16 ± 0.39b	0.19 ± 0.49b	0.61 ± 3.07b
Contrast increment protocol
10% (n = 17)	0.14 ± 0.07b	0.14 ± 0.30	0.19 ± 0.46	0.79 ± 3.39
5% (n = 16)	0.14 ± 0.09b	0.12 ± 0.45	0.15 ± 0.38	0.65 ± 3.06
0% (n = 14)	0.13 ± 0.09b	0.16 ± 0.32	0.24 ± 0.64b	−0.76 ± 3.17
10% + reset (n = 16)	0.16 ± 0.09b	0.22 ± 0.49	0.18 ± 0.35	1.49 ± 2.49b
Age group
4.0–7.4 years	0.17 ± 0.08b	0.19 ± 0.43	0.23 ± 0.38b	0.43 ± 3.05b
7.5–10.9 years	0.12 ± 0.08b	0.13 ± 0.37	0.15 ± 0.57b	0.75 ± 3.09

AE BCVA, amblyopic eye best-corrected visual acuity; CBI, contrast balance index; logMAR, logarithm of the minimum angle of resolution; RDS, random dot stereoacuity.

^aResults presented as mean and standard deviation.

^bSignificant improvement from baseline.